1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ION251: new trials by email Literature Review of ION251 trials Research Report on ION251
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ION251 Administered to Patients With Relapsed/Refractory Multiple Myeloma ION251 - Relapsed Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | Completed | Ionis Pharmaceuticals, Inc. | 23 | 2021-01-20 | 2024-10-31 |
Multiple Myeloma (1)
Ionis Pharmaceuticals, Inc. (1)
United States (1)